Results
3630
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
3,630 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GSIW | US$0.47 | 0.6% | -96.8% | US$9.0m | n/a | PS5.6x | n/a | n/a | Diversified Financials | ||
SHYF | US$12.19 | 3.2% | 15.9% | US$414.5m | US$15.00 | PS0.5x | E102.7% | 1.6% | Capital Goods | ||
UK | US$1.14 | -1.7% | -56.0% | US$1.6m | n/a | PS0.04x | n/a | n/a | Real Estate Management and Development | ||
ORBN | US$20.15 | -4.0% | -1.9% | US$49.6m | n/a | PB0.7x | n/a | 4.0% | Banks | ||
AFYA | US$16.80 | 2.0% | -17.2% | US$1.5b | US$19.34 | PE15.1x | E21.8% | n/a | Consumer Services | ||
CRSB | US$38.00 | 4.7% | 26.7% | US$55.6m | n/a | PB1.3x | n/a | n/a | Banks | ||
AUUD | US$0.44 | -2.8% | -90.7% | US$2.2m | US$25.00 | PB0.4x | E5.9% | n/a | Software | ||
SPWH | US$1.79 | -8.2% | -53.0% | US$71.7m | US$3.30 | PS0.06x | E49.8% | 0% | Retail | ||
IMMR | US$8.29 | 0% | 4.0% | US$270.8m | US$13.75 | PE4x | E-24.3% | 2.2% | Tech | ||
NPCE | US$12.30 | -11.5% | -19.8% | US$373.7m | US$17.57 | PS4.8x | E32.6% | n/a | Healthcare | ||
CAAP | US$18.96 | -3.0% | 26.1% | US$3.2b | US$21.63 | PE9.1x | E5.9% | n/a | Transportation | ||
MRIN | US$2.07 | 3.0% | -10.2% | US$6.6m | n/a | PS0.4x | n/a | n/a | Software | ||
VRNA | US$59.33 | -1.0% | 249.8% | US$4.8b | US$65.75 | PS863.3x | E58.2% | n/a | Pharmaceuticals & Biotech | ||
EKSO | US$0.58 | 4.8% | -73.1% | US$12.6m | US$5.50 | PS0.7x | E59.4% | n/a | Healthcare | ||
AVDL | US$9.00 | 10.0% | n/a | US$875.9m | US$17.60 | PS6.3x | E55.4% | n/a | Pharmaceuticals & Biotech | ||
MIRA | US$1.14 | 0.9% | 8.6% | US$19.4m | US$12.63 | PB5.3x | E8.5% | n/a | Pharmaceuticals & Biotech | ||
CWPE | US$0.097 | -20.4% | -61.5% | US$2.0m | n/a | PE50.6x | n/a | n/a | Energy | ||
CLFD | US$34.13 | -4.1% | 18.8% | US$487.7m | US$46.00 | PS2.9x | E132.6% | n/a | Tech | ||
NUTX | US$58.80 | 20.8% | 247.5% | US$311.3m | US$55.33 | PS1.1x | E121.2% | n/a | Healthcare | ||
YCBD | US$0.55 | -4.2% | -21.6% | US$3.1m | US$2.00 | PS0.2x | n/a | n/a | Pharmaceuticals & Biotech | ||
ROL | US$49.94 | 1.8% | 13.9% | US$24.2b | US$48.85 | PE51.5x | E10.7% | 1.3% | Commercial Services | ||
ORBT | US$4.00 | 0% | -11.1% | US$13.3m | n/a | PS0.5x | n/a | 0% | Capital Goods | ||
RVCB | US$24.00 | 0% | 15.4% | US$74.6m | n/a | PB1.4x | n/a | n/a | Banks | ||
BROS | US$64.19 | -0.7% | 141.5% | US$11.8b | US$64.58 | PE241.6x | E41.5% | n/a | Consumer Services |